Mystery Patient, Age 79, Got Special Access to Weight Drug

One of the more intriguing stories of the day comes from STAT News , which reports that a well-connected patient received "extraordinary" early access to an experimental obesity drug from Eli Lilly. Speculation that it might be President Trump is part of the story. The access to retatrutide came last year...